Navigation Links
OSI Pharmaceuticals Announces Pivotal Phase III Tarceva Study,Published in the Journal of Clinical Oncology Showed Survival,Improvement in Patients with Pancreatic Cancer

a through partnerships with Genentech, Inc. in the United States and with Roche throughout the rest of the world. For additional information about OSI, please visit http://www.osip.com.

This news release contains forward-looking statements. These statements are subject to known and unknown risks and uncertainties that may cause actual future experience and results to differ materially from the statements made. Factors that might cause such a difference include, among others, the completion of clinical trials, the FDA and other foreign review processes and other governmental regulation, OSI's and its collaborators' abilities to successfully develop and commercialize drug candidates, competition from other pharmaceutical companies, the ability to effectively market products, and other factors described in OSI Pharmaceuticals' filings with the Securities and Exchange Commission.

Contact

OSI Pharmaceuticals, Inc.
Kathy Galante (Investors/Media)
Senior Director
631-962-2043
or
Kim Wittig (Media)
Director
631-962-2135
or
Burns McClellan, Inc. (representing OSI)
Lauro Siino (Investors)
212-213-0006
or
Kathy Nugent (Media)
205-401-0260


'"/>




Page: 1 2 3 4

Related medicine technology :

1. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
2. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
3. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
4. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
5. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
6. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
7. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
8. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
9. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
10. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
11. Arisaph Pharmaceuticals Announces Results of its Potent Smart DPP-4 Inhibitor, ARI-2243, at the ADA
Post Your Comments:
(Date:8/29/2014)... Research and Markets has announced ... Market & Pipeline Insight 2014" report to their ... prevent and eradicate the prevalence of cancer have achieved ... to low specificity, safety and large number of side ... better solution. It has been discovered that peptides can ...
(Date:8/29/2014)... SILVER SPRING, Md. , Aug. 29, 2014 /PRNewswire/ ... today that the U.S. District Court for the District ... in its favor in the company,s case against Sandoz, ... opinion, Judge Peter Sheridan ruled that U.S. ... Sandoz, Inc., and enjoined Sandoz from marketing its generic ...
(Date:8/29/2014)... /PRNewswire-iReach/ -- ChemImage will present a workshop focused on ... Forensic Science Society,s 22 nd International Symposium ... Australia .  Forensic Scientists will be in ... imaging can bring to examination procedures. ... Product Development at ChemImage, will host a workshop ...
Breaking Medicine Technology:Global Peptide Cancer Therapeutics Market & Pipeline Insight 2014 2District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3
... 2007--In this weeks issue of Science,researchers from the ... University in Sweden report an,important discovery about a ... epsilon plays in replicating DNA in higher organisms,such ... study places us one step closer to understanding ...
... 05, 2007 /PRNewswire/ -- Results from,the primary ... study showed that 77 percent of treatment-experienced ... tablets with,100 mg ritonavir (PREZISTA/r) twice daily, ... (ARV) agents, reached a,plasma viral load of ...
Cached Medicine Technology:NIEHS Researchers Identify Enzyme Critical in DNA Replication 2NIEHS Researchers Identify Enzyme Critical in DNA Replication 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 2New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 3New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 4New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 5New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 6New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 7New Phase 3 Study Published in The Lancet Evaluates Efficacy and,Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination,Therapy in Treatment-Experienced Adults With HIV 8
(Date:8/30/2014)... 30, 2014 Daily Gossip reveals in its ... Him Desire You program, who shows a unique formula to ... of this method says that the program goes beyond mere ... Him Desire You review indicates that the program was created ... and his great techniques to make a man feel emotionally ...
(Date:8/30/2014)... RB SEO Services, a well-recognized internet marketing ... businesses. , RBSEO Services knows this very well that ... optimization service. So, the company has introduced this service, ... , On being asked about the service, a senior ... SEO service because many small businesses expressed their inability ...
(Date:8/30/2014)... 2014 Market Research Report on ... a professional and in-depth market survey on Global ... reviews the basic information of Cell Disruptor including ... then explores global and China’s top manufacturers of ... value, and market share etc. The report further ...
(Date:8/30/2014)... Randy Dotinga HealthDay ... About one in five patients operated on for broken bones ... surgery, a new study finds. Less-educated patients and ... more likely to be "doctor shoppers," said study lead author ... Ky. Overall, he said, the study suggests that doctors aren,t ...
(Date:8/30/2014)... Dallas, Texas (PRWEB) August 30, 2014 ... Lab Oven Industry, 2009-2019 is a professional and ... Oven industry. The report firstly reviews the basic ... and manufacturing technology. The report then explores global ... their product specification, capacity, production value, and market ...
Breaking Medicine News(10 mins):Health News:Make Him Desire You Review Reveals Powerful Formula to Make a Man Emotionally Addicted 2Health News:RBSEO Services Introduces Low Cost SEO Service for Small Businesses 2Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 2Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 3Health News:Cell Disruptor Industry Global and Chinese Analysis for 2009-2019 in New Research Report at ReportsnReports.com 4Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 2Health News:'Doctor-Shopping' for Painkillers Common After Broken-Bone Surgery, Study Finds 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 2Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 3Health News:Lab Oven Industry for Global and Chinese Market Forecasts to 2019 in New Research Report Available at ReportsnReports.com 4
... assistant professor of psychology in the School of Science ... Center for Aging Research affiliated scientist, has received a ... whether treatment of depression before one experiences a heart ... The research study, Beating the Blues for ...
... way to immobilise radioactive forms of iodine using a microwave, ... Sheffield. Iodine radioisotopes are produced by fission of uranium ... concern because it is highly mobile in the environment and ... cancer risk following long term exposure. Furthermore, iodine-129, which is ...
... HealthDay Reporter , MONDAY, May 23 (HealthDay News) -- Cutting ... pain and foregoing annual ECG screenings for healthy, low-risk patients ... experts say. Perhaps taking a page from David Letterman,s ... up with a "Top 5" list of action items for ...
... concern about the effects of media violence on children, ... and marketed to them. An Indiana University research study ... of such programs and their characters. In a ... , Andrew J. Weaver, an assistant professor of telecommunications ...
... that quality of life means more than just material ... to be interested in letting people,s subjective well-being guide ... in Ethiopia, a city of three million people, shows ... citizens themselves consider to make them satisfied with life. ...
... MONDAY, May 23 (HealthDay News) -- Women who gained 18 or ... three times more likely to develop gestational diabetes during their second ... the study, published in the May 23 online issue of ... to shed six or more pounds between babies cut their risk ...
Cached Medicine News:Health News:IUPUI study first to look at early treatment of depression to reduce heart disease risk 2Health News:Expert discovers simple method of dealing with harmful radioactive iodine 2Health News:Experts Issue 'Top 5' List for Better Primary Care 2Health News:Experts Issue 'Top 5' List for Better Primary Care 3Health News:New study finds that violence doesn't add to children's enjoyment of TV shows, movies 2Health News:New study finds that violence doesn't add to children's enjoyment of TV shows, movies 3Health News:What do policymakers know about the factors influencing people's well-being? 2Health News:Losing Baby Weight Cuts Odds of Pregnancy-Linked Diabetes 2
Neuropack Sigma MEB-5500 series evoked potential measuring system is a compact, portable, all-in-one unit....
... 1200/1400/1800 units are based on ... the ISA 100x EP amplifiers ... select input units with 2 ... EP), 4 channels (ISA 1004, ...
Solid steel construction for lifelong quality. Strong, smooth and quiet electro-mechanical up/down movement. Dual castor, locking wheels for use on carpet or tile flooring. Easy cleaning, deluxe lami...
Trial lens set +/- Cyl....
Medicine Products: